Sign In
to Vote &
Create Storyboards.
 
Accuray Incorporated (Nasdaq: ARAY), has announced the publication of two papers stemming from a large multi-center study of CyberKnife® stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles(UCLA). The first paper, published in the September 2013 online issue of Radiotherapy & Oncology (commonly referred to as the Green Journal), found, in more than one thousand patients with organ-confined prostate cancer, relapse-free survival rates were compa...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard